Category results for "Prescription Drugs"

Zohydro Sales Banned in Massachusetts

The pure hydrocodone drug Zohydro ER (extended release) will be banned in Massachusetts, Governor Deval Patrick has announced. He cited a public health emergency stemming from opioid abuse, Reuters reports.

Zohydro Maker Assembles Oversight Board Designed to Spot Misuse of Drug

The manufacturer of the recently approved pure hydrocodone drug Zohydro ER (extended release) announced it will assemble an oversight board designed to spot misuse of the drug, the Associated Press reports.

JT Weekly- Other Headlines of Interest

Top headlines of the week from Friday, March 21- Thursday, March 27, 2014.

Young Adults Who Occasionally Use Cocaine or Amphetamines Show Brain Changes

Young adults who occasionally use stimulants including cocaine, amphetamines or prescription drugs such as Adderall show brain changes on scans, according to researchers at the University of California, San Diego.

Emergency Departments Prescribing More Opioid Painkillers

Emergency departments are prescribing more opioid painkillers than in previous years for problems such as headaches or low back pain, a new study concludes. Many of these patients could be treated with over-the-counter painkillers, experts say.

States Consider Synthetic Drug Bans, Opioid Education for Doctors and Marijuana Laws

A number of state legislatures are considering bills banning synthetic drugs, requiring education for doctors who prescribe opioids, and expanding the use of the drug overdose antidote naloxone this session, explains Sherry Green, CEO of the National Alliance for Model State Drug Laws.

FDA Commissioner: Zohydro Offers Unique Option to Treat Pain

Food and Drug Administration Commissioner Margaret Hamburg defended the agency’s decision to approve the pure hydrocodone drug Zohydro ER (extended release). At a Senate hearing, Hamburg said, “If appropriately used, it serves an important and unique niche with respect to pain medication and it meets the standards for safety and efficacy.”

OxyContin Manufacturer Tests Tamper-Resistant Form of Hydrocodone

The maker of OxyContin announced promising results from a study of a tamper-resistant form of hydrocodone, The Washington Post reports. The Food and Drug Administration has been criticized for approving Zohydro ER (extended release), a pure form of hydrocodone that is not tamper-resistant.

Study: Effectiveness of Prescription Monitoring Databases Varies Greatly by State

The effectiveness of prescription drug monitoring programs, designed to reduce “doctor shopping” for opioids, has varied greatly by state, according to a new study by Columbia University researchers.

JT Weekly- Other Headlines of Interest

Top headlines of the week from Friday, March 7- Thursday, March 13, 2014.

Page 2 of 75123...10...